150 unknown. 150 Phase 2, 31 Phase 1, 12 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 150 | Unknown 150 |
| Phase 1 | 31 | Unknown 31 |
| Phase 3 | 12 | Unknown 12 |
Follow Prostatic Neoplasms: new trials by email Literature Review of Prostatic Neoplasms trials Research Report on Prostatic Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Impact of Medication Timing Adjustment on the Effect of Novel Hormonal Therapy Receive Abiraterone plus prednisone/Enzalutamide/Apalutamide/Rezvilutamide in the evening - Prostate Cancer | Phase 2 | Unknown | Sun Yat-sen University | 70 | 2024-08-01 | 2024-08-05 |
| Docetaxel Alone or in Combination With Enzalutamide for mCRPC Previously Treated With Abiraterone at mHSPC Stage Enzalutamide 40 MG, Docetaxel injection - Prostate Cancer, Castrate Resistant Prostate Cancer | Phase 2 / Phase 3 | Unknown | Zhongnan Hospital | 120 | 2024-06-01 | 2024-02-28 |
| To Assess The Patient Preference for Goserelin Microsphere Versus Goserelin Implant in Patients With Prostate Cancer Zoladex, LY01005 - Prostate Cancer | Phase 2 | Unknown | The First Affiliated Hospital of Xiamen University | 60 | 2024-05-01 | 2024-04-26 |
| Rezvilutamide Plus Abiraterone for Metastatic Hormone-sensitive Prostate Cancer Rezvilutamide, Rezvilutamide plus abiraterone, Continue previous treatment - Metastatic Hormone-Sensitive Prostate Cancer | Phase 2 | Unknown | Jianbin Bi | 160 | 2023-11-15 | 2023-11-18 |
| A Phase II Neoadjuvant Study of Darolutamide Plus ADT in Men With Localized Prostate Cancer Darolutamide+ADT - Prostate Cancer | Phase 2 | Unknown | Peking University First Hospital | 53 | 2023-08-05 | 2023-12-12 |
| A Phase 2 Trial of Darolutamide as a Prostate-Specific Membrane Antigen (PSMA) Expression Enhancer in Patients With Localized Prostate Cancer Darolutamide Oral Tablet [Nubeqa] - Prostate Cancer | Phase 2 | Unknown | D'Or Institute for Research and Education | 19 | 2023-07-20 | 2023-08-07 |
| Tracer-Guided Surgery for Recurrent Prostate Cancer PSMA-radioguided surgery, ADT - Prostate Cancer | Phase 2 | Unknown | The Netherlands Cancer Institute | 60 | 2023-02-15 | 2023-10-06 |
| [Lu-177]Ludotadipep in Castration-resistant Prostate Cancer(CRPC): Investigation of Drug and Application_2 [177Lu]Ludotadipep - Metastatic Castration-resistant Prostate Cancer, mCRPC | Phase 2 | Unknown | FutureChem | 20 | 2022-10-30 | 2024-04-29 |
| Early Salvage Stereotactic Radiotherapy for Biochemical Failure After RP salvage SBRT - Prostatic Neoplasm | Phase 2 | Unknown | Regina Elena Cancer Institute | 103 | 2022-09-27 | 2022-12-28 |
| EVOLUTION: 177Lu-PSMA Therapy Versus 177Lu-PSMA in Combination With Ipilimumab and Nivolumab for Men With mCRPC 177Lu-PSMA-617, Ipilimumab, Nivolumab - Prostatic Neoplasms, Genital Neoplasms, Male | Phase 2 | Unknown | Australian and New Zealand Urogenital and Prostate Cancer Trials Group | 93 | 2022-04-29 | 2023-12-15 |
| Enhanced Systemic Combined With Local Treatment for Primary and Metastatic Lesions in Oligo-metastatic Prostate Cancer Leuprolide acetate, Goserelin acetate, Triptorelin acetate - Prostate Cancer | Phase 2 | Unknown | Fudan University | 160 | 2022-04-01 | 2022-03-16 |
| 64Cu-SAR-bisPSMA Positron Emission Tomography of Patients With Known or Suspected Prostate Cancer 64Cu-SAR-bisPSMA - Prostate Cancer | Phase 1 / Phase 2 | Unknown | Luke Nordquist, MD | 150 | 2022-03-28 | 2022-03-18 |
| The Study of Olaparib Combined With Abiraterone and Prednisone in mHSPC Patients With HRR Gene Mutation Olaparib tablet, Abiraterone acetate, Prednisone tablet - Prostate Cancer, Prostate Carcinoma | Phase 2 | Unknown | Hongqian Guo | 30 | 2022-03-01 | 2022-10-25 |
| TQB3616 Capsules Combined With Abiraterone Acetate Plus Prednisone in Metastatic Castration-Resistant Prostate Cancer TQB3616 Capsules Combined With Abiraterone Acetate Plus Prednisone - Prostatic Neoplasms, Castration-Resistant, Drug Therapy, Combination | Phase 2 | Unknown | West China Hospital | 30 | 2022-01-01 | 2021-12-14 |
| Efficacy and Safety of Darolutamide Combined With ADT in High-risk/Very High-risk Localized Prostate Cancer Darolutamide 300 mg, Androgen deprivation therapy - Prostate Cancer | Phase 2 | Unknown | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 30 | 2022-01-01 | 2023-01-03 |
| The Study of Olaparib in Newly Diagnosed mCRPC Patients With HRR Gene Mutation Olaparib - Prostate Cancer, Prostate Carcinoma | Phase 2 | Unknown | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 30 | 2021-12-07 | 2022-03-02 |
| A Comparison of Aerobic and Resistance Exercise to Counteract Treatment Side Effects in Men With Prostate Cancer Exercise - Exercise, Prostate Cancer | Phase 1 / Phase 2 | Unknown | Kira Murphy | 24 | 2021-09-09 | 2021-12-14 |
| Administration of Antibiotic Prophylaxis for Transperineal Prostate Biopsy in Cipto Mangunkusumo Hospital Cotrimoxazole, Placebo - Prostate Cancer, Prostate Biopsy | Phase 2 | Unknown | Universitas Indonesia | 78 | 2021-07-06 | 2021-08-05 |
| Al18F-PSMA-617 and 68Ga-PSMA-617 PET/CT Imaging in the Same Group of Prostate Cancer Patients Al18F-PSMA-617, 68Ga-PSMA-617 - Prostate Cancer | Phase 2 / Phase 3 | Unknown | Peking Union Medical College Hospital | 100 | 2021-07-01 | 2023-05-03 |
| The Effect of Metformin in Patients With Metastatic Castration-resistant Prostate Cancer Metformin - Metastatic Prostate Cancer | Phase 2 | Unknown | Sun Yat-sen University | 234 | 2021-06-23 | 2021-06-14 |
Showing 20 of 150. Sign in to see all of them.
Neoplasms (8) · Carcinoma, Non-Small-Cell Lung (6) · Breast Neoplasms (5) · Neoplasm Metastasis (5) · Stomach Neoplasms (4) · Genital Neoplasms, Male (3) · Neoplasms by Site (3) · Pancreatic Neoplasms (3) · Prostatic Diseases (3) · Urogenital Neoplasms (3) · Adenoviridae Infections (2) · Carcinoma, Renal Cell (2) · Colonic Neoplasms (2) · Endometrial Neoplasms (2)
Genital Diseases (150) · Male Urogenital Diseases (150) · Urogenital Diseases (150) · Genital Diseases, Male (149) · Genital Neoplasms, Male (147) · Neoplasms by Site (147) · Prostatic Diseases (147) · Urogenital Neoplasms (147) · Neoplasms (142) · Pathological Conditions, Signs and Symptoms (14) · Pathologic Processes (11) · Female Urogenital Diseases (7) · Female Urogenital Diseases and Pregnancy Complications (7) · Neoplastic Processes (7) · Bronchial Neoplasms (6)
Docetaxel (15) · Abiraterone Acetate (11) · Radiosurgery (9) · Prednisone (8) · Radiotherapy (8) · enzalutamide (8) · Goserelin (7) · Androgen Antagonists (5) · Leuprolide (4) · abiraterone (4) · acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide (4) · apalutamide (4) · cabazitaxel (4) · Estramustine (3) · Gonadotropin-Releasing Hormone (3)
Sunnybrook Health Sciences Centre (5) · Fudan University (3) · University College London Hospitals (3) · West China Hospital (3) · CyberKnife Centers of San Diego (2) · Department of Veterans Affairs, New Jersey (2) · Juravinski Cancer Center (2) · Mansoura University (2) · Novacea (2) · Peking Union Medical College Hospital (2) · Radboud University Medical Center (2) · Roll International Corporation (2) · Royal Marsden NHS Foundation Trust (2) · Spanish Oncology Genito-Urinary Group (2) · Sun Yat-sen University (2)
United States (37) · China (23) · Canada (19) · United Kingdom (8) · Australia (5) · Belgium (5) · Netherlands (5) · Spain (5) · Brazil (4) · France (4) · Italy (4) · Egypt (3) · Israel (3) · South Korea (3) · Germany (2)
Alfonso Gomez-Iturriaga, MD, PhD (2) · Allan J Pantuck, MD (2) · Arie S Belldegrun, MD (2) · Basil Kasimis, MD (2) · Donald B Fuller, M.D. (2) · Laurence Klotz, MD (2) · Mark Emberton, MD, FRCS, MBBS (2) · Michiel Sedelaar, MD, PhD (2) · Yonghong Li, M.D. (2) · Abolfazl Razzaghdoust (1) · Ahmed Shokeir, PhD (1) · Alfonso Gomez-Iturriaga, MD (1) · Anders Widmark, Prof MD (1)
PMID 12126818, PMID 15042609, PMID 15143084, PMID 15470213, PMID 15470214, PMID 16985954, PMID 17587390, PMID 18930581, PMID 19091394, PMID 19286225, PMID 19308068, PMID 19359544, PMID 19399748, PMID 19996060, PMID 21470407, PMID 22056152, PMID 22500211, PMID 22614062, PMID 22866066, PMID 22894553, PMID 22932804, PMID 23063623, PMID 23619389, PMID 24290503, PMID 24321502, PMID 24412228, PMID 24464861, PMID 24472709, PMID 24821581, PMID 25104109, PMID 25217422, PMID 25566502, PMID 25682339, PMID 25687533, PMID 25819287, PMID 25888263, PMID 25937426, PMID 26215782, PMID 26309896, PMID 27150293, PMID 27296781, PMID 27836248, PMID 28498618, PMID 29153462, PMID 29606109, PMID 30528653, PMID 30545809, PMID 32356465, PMID 33102224, PMID 33203399
2016 (3), 2017 (2), 2008 (1), 2015 (1), 2019 (1), P30CA060553 (1), P30CA093373 (1)